Skip to Content

Tag: Carolina's


In brief: Invacare sticks to target, Quality Biomedical takes on investor

September 13, 2019HME News Staff

ELYRIA, Ohio - Invacare reaffirmed its long-term target of $85 million to $105 million adjusted EBITDA run-rate by the fourth quarter of 2020 at the Baird Global Healthcare Conference in New York on Sept. 4.Invacare's Matt Monaghan said the company expects to achieve the goal through a combination of net sales growth driven by new product introductions, supply chain actions to expand gross margin and cost-optimization initiatives to meaningfully reduce SG&A expense.“After four years of foundation...

Carolina's, ExceleraRx, Invacare, NSM, Quality Biomedical, WellSky

Read Full Articlered right arrow icon